Key result
Cardiac imaging, especially CMR late gadolinium enhancement, refines sudden cardiac death risk stratification in HCM.
Why the study?
Accurate SCD risk stratification in HCM remains challenging because conventional algorithms do not fully capture the disease's heterogeneous arrhythmic substrate.
Advanced cardiac imaging techniques, particularly cardiovascular magnetic resonance and echocardiography, are essential for refining sudden cardiac death risk assessment in patients with hypertrophic cardiomyopathy beyond conventional clinical algorithms.
Supports LGE-CMR integration into HCM SCD models; extends algorithms but leaves open prospective validation before practice change.
Hypertrophic cardiomyopathy (HCM) is a common inherited myocardial disorder and a leading cause of sudden cardiac death (SCD) across all age groups. Accurate risk stratification remains a clinical challenge, as conventional algorithms fail to fully capture the heterogeneous arrhythmic substrate of the disease. In recent years, cardiac imaging has emerged as a pivotal tool for refining SCD prediction by providing detailed structural, functional, and tissue-characterisation data. This review offers a comprehensive synthesis of imaging-derived predictors of SCD in HCM. We examine established echocardiographic markers, including maximal left ventricular wall thickness, left ventricular ejection fraction and left ventricular outflow tract obstruction, together with advanced cardiovascular magnetic resonance parameters such as late gadolinium enhancement and apical aneurysm detection. In addition, we discuss the emerging role of extracellular volume expansion, quantitative mapping techniques, and strain abnormalities within the framework of contemporary risk stratification models. By bridging imaging biomarkers with underlying pathophysiological mechanisms, this review highlights current evidence, limitations, and future directions to improve precision in SCD risk assessment in HCM.
No takes yet. Share an insight, caveat, or question.
Rifé-Pardo et al. (2026) conducted a review in Hypertrophic cardiomyopathy. Cardiac imaging markers was evaluated. Cardiac imaging markers, particularly late gadolinium enhancement on cardiovascular magnetic resonance, refine sudden cardiac death risk stratification in hypertrophic cardiomyopathy beyond conventional algorithms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: